Illustrative image – not actual.Orchid Chemicals & Pharmaceuticals has completed the transaction for sale and transfer of its generic injectable finished dosage forms pharmaceuticals business to Hospira Healthcare India.
The company had entered into a business transfer agreement on 15 December 2009, to sell its injectable business to Hospira for $400 million (approx Rs 1,860 crore). The transaction includes Orchid's betalactam antibiotics injectables manufacturing complex and formulations R&D facility at Irungattukottai, Chennai.
